Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Biocryst Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get BCRX alerts

About Thomas R. Staab II

Thomas R. Staab II is recorded as CFO at Biocryst Pharmaceuticals Inc (BCRX). The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $692,790 for Thomas R. Staab II in fiscal 2020, including a base salary of $77,113. Disclosed compensation is on record for 4 fiscal years. Biocryst Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Biocryst Pharmaceuticals Inc includes Charles Gayer (CEO and Board Member), Charlie Gayer (CEO and Board Member), Vincent J. Milano (Chairman and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at Biocryst Pharmaceuticals Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Biocryst Pharmaceuticals Inc (BCRX) $77,113 $692,790
2019 Biocryst Pharmaceuticals Inc (BCRX) $462,679 $910,354
2018 Biocryst Pharmaceuticals Inc (BCRX) $449,203 $1,797,270
2017 Biocryst Pharmaceuticals Inc (BCRX) $434,002 $1,723,588

Recent activity

No call appearances or filed executive changes recorded yet.